Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

EQRX

EQRx (EQRX)

EQRx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EQRX
DateTimeSourceHeadlineSymbolCompany
21/11/202308:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:EQRXEQRx Inc
20/11/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EQRXEQRx Inc
20/11/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EQRXEQRx Inc
20/11/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EQRXEQRx Inc
10/11/202308:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQRXEQRx Inc
10/11/202308:05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EQRXEQRx Inc
10/11/202308:04Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EQRXEQRx Inc
10/11/202308:03Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EQRXEQRx Inc
10/11/202308:01Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EQRXEQRx Inc
10/11/202308:01Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EQRXEQRx Inc
10/11/202301:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
09/11/202303:30GlobeNewswire Inc.Revolution Medicines and EQRx Stockholders Approve EQRx AcquisitionNASDAQ:EQRXEQRx Inc
07/11/202308:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQRXEQRx Inc
01/11/202323:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:EQRXEQRx Inc
01/11/202322:59Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/11/202322:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
16/08/202322:07Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
09/08/202307:29Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
09/08/202307:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQRXEQRx Inc
04/08/202306:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
02/08/202306:38Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
02/08/202306:32Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
02/08/202306:31Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
02/08/202306:29Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/08/202321:25Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/08/202321:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
01/08/202321:00GlobeNewswire Inc.Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional CapitalNASDAQ:EQRXEQRx Inc
04/07/202308:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQRXEQRx Inc
09/05/202307:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EQRXEQRx Inc
09/05/202306:01GlobeNewswire Inc.EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial ResultsNASDAQ:EQRXEQRx Inc
 Showing the most relevant articles for your search:NASDAQ:EQRX